Drug Master Files, manufacturer listings, and Electronic Common Technical Document (eCTD) submissions are foundational to regulatory compliance. Yet even experienced regulatory, quality, and operations...
The global Unique Device Identification (UDI) landscape is entering a critical enforcement phase — and 2026 will be a challenging year for medical device manufacturers operating in the European Union...
The FDA’s final rule, “Revising the National Drug Code Format and Drug Label Barcode Requirements,” establishes a uniform 12-digit format for FDA-assigned National Drug Codes (NDCs) ...
UDI product data is now due for specific scenarios (enforced as of December 8, 2022). Class I and Unclassified medical devices that are required to be labeled with a UDI code must submit product data...
LexisNexis Life Sciences Solutions and ONIX expand strategic alliance to guide pharma customers to market faster Professionals in the life sciences industry rely on unique regulatory affairs expertise...
The European Union (EU) requires manufacturers to supply ‘implant cards’ for patients with implanted medical devices, as prescribed in Article 18 of Regulation (EU) 2017/745 on medical devices. The requirement’s purpose is to give patients easy access to important information about their implants. Providers or medical institutions are to deliver the implant cards to patients, but device manufacturers will be responsible for producing the cards with specific formatting, information, and language requirements.
The wallet-sized cards, unique to the implanted medical device, are designed to support patient safety in three ways:
Guidelines from the Medical Device Coordination Group (MDCG) of the EU provides a non-exhaustive list of medical devices that fall under the regulation for implant cards. The list of more than 85 devices includes pacemakers, lumbar shunts, intraocular lenses, coronary stents, breast implants, and gastric bands. Exempted from the regulation are “simple” implants such as dental fillings, tooth crowns, pins, and sutures.
According to MDCG guidance, the implant cards must be the size of a credit card, ATM card, or ID card. Text, including numbers, letters, and symbols, must be at least two millimeters high and written so it can be easily understood by a layperson and in the language determined by the relevant member state.
The card should list the following information about the implant:
The card also must include blank fields for patient identification information, which will be filled out by the implanting provider or healthcare institution. This information gives:
With multiple nations affected by the implant card requirement, the MDCG advises manufacturers to use approved symbols to provide a common “shorthand” for all stakeholders and avoid national versions of the cards. A guide to the symbols and instructions for healthcare professionals on how to fill out the implant card should be included in shipments to providers and healthcare institutions. It is recommended that manufacturers provide this information in a leaflet written in the language required by the member state. Manufacturers are also advised to update any relevant implant card information via a patient-accessible website listed on the card.
Example: Suggested design of a foldable implant card
Now that the MDR Date of Application has passed, per Article 18 of the MDR, manufacturers of some implantable devices are obligated to provide a patient implant card as EUDAMED becomes fully available.
As guidance continues to develop for UDI and device registration for MDR/IVDR, LexisNexis Life Sciences stands ready to navigate the complexity for medical device manufacturers and other stakeholders.
Contact us
MDCG 2021-11 Guidance on Implant Card – Device types (May 2021)
Factsheet for Manufacturers of Implantable Medical Devices
Guidance on Implant Card – Device types